Navigation Links
Northwest Biotherapeutics to Present at Inaugural Cancer Immunotherapy Conference
Date:10/14/2010

ancer, and clearance from the FDA for Phase I trials in five other cancers.  The Company has also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer.  The Company's second technology platform, involving antibodies to CXCR4, is at the pre-clinical development stage.

For further information about clinical sites and Company information please visit the company web site at www.nwbio.com.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients with GBM using DCVax®-Brain and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capital, risks related to the Company's ability to enroll patients in its clinical trials and complete the trials on a timely basis, the uncertainty of the clinical trials process, uncertainties about the timely performance of third parties, and whether the Company's products will demonstrate safety and efficacy.  Additional information on these and other factors, including Risk Factors, which could affect the Company's results, is included in its Securities and Exchange Commission ("SEC") filings.  Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement.  You should not place undue reliance on any for
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Northwest Biotherapeutics Raises Funding and Proceeds With Balance Sheet Restructuring
2. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
3. Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.
4. Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory (PNNL), USA
5. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
6. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
7. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
8. Oncothyreon to present at Invest Northwest 2009
9. Sirius Genomics to Present at Invest Northwest Conference
10. Northwest Biotherapeutics Secures $700,000 Equity Financing
11. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2013)... 2013  Stem cells have long been touted as the ... to Dr. Dennis Lox , some patients with a ... to stem cell therapy for aid. Avascular necrosis (AVN) also ... in which the blood supply to the bone becomes disrupted, ... to as necrosis. The region may be very painful, and ...
(Date:6/14/2013)... DIEGO , June 14, 2013  Mast Therapeutics, ... an underwritten public offering of 50,000,000 units, each unit ... common stock and one warrant to purchase 0.5 of ... price of $0.50 per unit.  The units will not ... stock and the warrants are immediately separable and will ...
(Date:6/14/2013)... Toronto, ON / Boston, MA (PRWEB) June 14, ... the world’s largest independent resource for life scientists ... new e-commerce features within the growing 1DegreeBio marketplace. ... quickly browse through hundreds of vendor catalogues, access ... create purchase orders, email products to lab managers ...
(Date:6/13/2013)... Eagle Biosciences is proud to announce ... Calprotectin ELISA assay kit that offers the ... µg/g stool). The Calprotectin ELISA assay kit is ... Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in ... assay line which already includes Alpha 1 Antitrypsin ...
Breaking Biology Technology:Stem Cells May Help Some With Avascular Necrosis (AVN) 2Mast Therapeutics Prices Public Offering Of Units 2Mast Therapeutics Prices Public Offering Of Units 3Mast Therapeutics Prices Public Offering Of Units 41DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform 2Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
... Mass., May 9 Millstone Medical Outsourcing,announced ... ISO 13485,certified quality system to the Memphis, ... the world,s largest developer and,publisher of international ... a highly-experienced quality engineer, to serve as ...
... 9 The International Center for Adult,Stem ... that,it has officially launched a global communications ... Spinal Cord Injury Symposium,Olfactory Mucosa Autografts (OMA) ... through May 10th in Argostolli, Kefalonia, Greece. ...
... announced financial results for the first quarter 2008. Novavax,reported a ... the first,quarter of 2008 compared to a net loss of ... 2007. Total cash and short-term investments,as of March 31, 2008 ... 2007. The cash burn for the quarter was $5.6 million., ...
Cached Biology Technology:Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager 2International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece 2Novavax Reports First Quarter 2008 Financial Results 2Novavax Reports First Quarter 2008 Financial Results 3Novavax Reports First Quarter 2008 Financial Results 4Novavax Reports First Quarter 2008 Financial Results 5Novavax Reports First Quarter 2008 Financial Results 6Novavax Reports First Quarter 2008 Financial Results 7Novavax Reports First Quarter 2008 Financial Results 8
(Date:6/14/2013)... will collaborate with researchers from Oklahoma State University, ... of Tulsa to advance understanding of how socio-ecological ... and variability in the state. , Oklahoma ... $20 million National Science Foundation Experimental Program to ... innovative research over the next five years. ...
(Date:6/14/2013)... work carried out by the Carbohydrate Metabolism Research ... jointly owned by the NUP/UPNA-Public University of Navarre, ... Government of Navarre), the discovery has been made ... (now renamed as the "surface composition regulator", scoR) ... in bacterial infection can be altered by manipulating ...
(Date:6/14/2013)... week in the journal Science , Swedish and ... million year old fossil fishes, revealed by unique fossils ... help scientists to understand how neck muscles and abdominal ... naturally conjures up a vision of rattling skeletons. Bones ... and are usually the only traces of the animal ...
Breaking Biology News(10 mins):OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 2Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 3
... This release is available in Spanish . ... oldest persons in the world, who recently died at the ... which could have contributed to this longevity. The research team, ... pointed out a healthy lifestyle, a Mediterranean diet, a temperate ...
... may have an important role to play in the fate ... recent war campaigns, according to a new report in the ... Press. The researchers found evidence that fungi can ... less likely to find its way into plants, animals, or ...
... plague may be more virulent than their close relatives because ... the May issue of the journal Microbiology. The plague ... body temperature. When there is no calcium available, it produces ... said Professor Brubaker from the University of Chicago, USA. We ...
Cached Biology News:The secret to long life may not be in the genes 2Fungi have a hand in depleted uranium's environmental fate 2
... Serum • Cyno serum is collected off the clot ... years of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD N-09: ...
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
adult...
DNA Purification...
Biology Products: